SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007617
Filing Date
2022-05-06
Accepted
2022-05-06 16:03:41
Documents
83
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20220331x10q.htm   iXBRL 10-Q 1717434
2 EX-10.4 icpt-20220331xex10d4.htm EX-10.4 147210
3 EX-31.1 icpt-20220331xex31d1.htm EX-31.1 9875
4 EX-31.2 icpt-20220331xex31d2.htm EX-31.2 9858
5 EX-32.1 icpt-20220331xex32d1.htm EX-32.1 10336
  Complete submission text file 0001558370-22-007617.txt   8959316

Data Files

Seq Description Document Type Size
6 EX-101.SCH icpt-20220331.xsd EX-101.SCH 53317
7 EX-101.CAL icpt-20220331_cal.xml EX-101.CAL 67049
8 EX-101.DEF icpt-20220331_def.xml EX-101.DEF 253129
9 EX-101.LAB icpt-20220331_lab.xml EX-101.LAB 414604
10 EX-101.PRE icpt-20220331_pre.xml EX-101.PRE 398233
77 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20220331x10q_htm.xml XML 2002394
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 22900984
SIC: 2834 Pharmaceutical Preparations